Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials (Q30947067)

27 June 2017

0 references

Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials (English)

1 reference

27 June 2017

0 references

1 reference

chronic heart failure

1 reference

3

Edzard Ernst

1 reference

27 June 2017

Max H Pittler

1

1 reference

PubMed ID

12798455

27 June 2017

Katja Schmidt

series ordinal

2

1 reference

PubMed ID

12798455

27 June 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

American Journal of Medicine

27 June 2017

1 reference

27 June 2017

114

1 reference

27 June 2017

8

1 reference

27 June 2017

665-674

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

27 June 2017

1 reference

Phytotherapy in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Herbs and dietary supplements in the prevention and treatment of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Review of the usefulness of contacting other experts when conducting a literature search for systematic reviews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Variance imputation for overviews of clinical trials with continuous response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-III heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Guidelines for the diagnosis and treatment of chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

ABC of heart failure. Acute and chronic management strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Diagnosis and management of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Beta-blockers for congestive heart failure: what is the current consensus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Drug treatment in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Clinical benefit of angiotensin-converting enzyme inhibitors in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Crataegus extract blocks potassium currents in guinea pig ventricular cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Incidence of hospitalization for digitalis toxicity among elderly Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

The existence of publication bias and risk factors for its occurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Publication bias in clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Bias in location and selection of studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Alternative therapy bias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Location bias in controlled clinical trials of complementary/alternative therapies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Language bias in randomised controlled trials published in English and German.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Bias against European journals in medical publication Databases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

Exercise testing in heart failure. A critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2803%2900131-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(03)00131-1

1 reference

27 June 2017

1 reference

PubMed ID

12798455